LEP and esophageal adenocarcinoma: Previous studies have found that higher circulating levels of certain metabolic and inflammatory biomarkers, including leptin, glucose, insulin, C-reactive protein, interleukin 6, and soluble tumor necrosis factor receptor 2, are associated with an increased risk of esophageal adenocarcinoma.27